192 related articles for article (PubMed ID: 12511533)
1. Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Palmieri V; Okin PM; Bella JN; Gerdts E; Wachtell K; Gardin J; Papademetriou V; Nieminen MS; Dahlöf B; Devereux RB;
Hypertension; 2003 Jan; 41(1):75-82. PubMed ID: 12511533
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
[TBL] [Abstract][Full Text] [Related]
3. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
Wachtell K; Olsen MH; Dahlöf B; Devereux RB; Kjeldsen SE; Nieminen MS; Okin PM; Papademetriou V; Mogensen CE; Borch-Johnsen K; Ibsen H
J Hypertens; 2002 Mar; 20(3):405-12. PubMed ID: 11875307
[TBL] [Abstract][Full Text] [Related]
4. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
Bang CN; Devereux RB; Okin PM
J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
[TBL] [Abstract][Full Text] [Related]
5. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
[TBL] [Abstract][Full Text] [Related]
6. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Dahlöf B
Hypertension; 2000 Nov; 36(5):766-73. PubMed ID: 11082141
[TBL] [Abstract][Full Text] [Related]
7. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point.
Okin PM; Devereux RB; Nieminen MS; Jern S; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Julius S; Dahlöf B
J Am Coll Cardiol; 2001 Aug; 38(2):514-20. PubMed ID: 11499746
[TBL] [Abstract][Full Text] [Related]
8. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B
Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
[TBL] [Abstract][Full Text] [Related]
9. Cornell product in an electrocardiogram is related to reduced LV regional wall motion.
Ishikawa J; Yamanaka Y; Watanabe S; Toba A; Harada K
Hypertens Res; 2019 Apr; 42(4):541-548. PubMed ID: 30542082
[TBL] [Abstract][Full Text] [Related]
10. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension.
Devereux RB; Roman MJ; Palmieri V; Okin PM; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Wachtell K; Dahlöf B
J Hypertens; 2000 Aug; 18(8):1129-38. PubMed ID: 10954006
[TBL] [Abstract][Full Text] [Related]
12. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
Okin PM; Devereux RB; Nieminen MS; Jern S; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Dahlöf B;
Circulation; 2006 Jan; 113(1):67-73. PubMed ID: 16365195
[TBL] [Abstract][Full Text] [Related]
13. Correlation between echocardiographic left ventricular mass index and electrocardiographic variables used in left ventricular hypertrophy criteria in Chinese hypertensive patients.
Xie L; Wang Z
Hellenic J Cardiol; 2010; 51(5):391-401. PubMed ID: 20876051
[TBL] [Abstract][Full Text] [Related]
14. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
Calderón A; Barrios V; Escobar C; Ferrer E; Barrios S; González-Pedel V; Montoro P; Navarro-Cid J
Clin Exp Hypertens; 2010 May; 32(3):145-53. PubMed ID: 20504121
[TBL] [Abstract][Full Text] [Related]
15. Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15-year prospective study.
Djordjevic DB; Tasic IS; Kostic ST; Stamenkovic BN; Lovic MB; Djordjevic ND; Koracevic GP; Lovic DB
Clin Cardiol; 2020 Sep; 43(9):1017-1023. PubMed ID: 32492247
[TBL] [Abstract][Full Text] [Related]
16. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure.
Okin PM; Wachtell K; Gerdts E; Dahlöf B; Devereux RB
J Hypertens; 2014 Dec; 32(12):2472-8; discussion 2478. PubMed ID: 25340854
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy.
Okin PM; Gerdts E; Kjeldsen SE; Julius S; Edelman JM; Dahlöf B; Devereux RB;
Hypertension; 2008 Jul; 52(1):100-6. PubMed ID: 18504323
[TBL] [Abstract][Full Text] [Related]
18. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
[TBL] [Abstract][Full Text] [Related]
19. Correlation between Echocardiographic Left Ventricular Hypertrophy and various Electrocardiographic Criteria of Left Ventricular Hypertrophy among Black Hypertensives.
Ngabea MA; Ojji DB; Sani MU; Isezuo SA
West Afr J Med; 2021 Jul; 38(7):695-700. PubMed ID: 34331528
[TBL] [Abstract][Full Text] [Related]
20. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]